Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
复制标题
长效生长抑素类似物 (SMS 201-995) 对胰腺霍乱患者的作用。
DOI:
--
复制
发表时间:
1985
影响因子:
158.5
通讯作者:
R. Jensen
中科院分区:
文献类型:
--
作者:
P. Maton;T. O'dorisio;B. Howe;K. Mcarthur;J. Howard;J. Cherner;T. Malarkey;M. Collen;J. Gardner;R. Jensen
PANCREATIC cholera is characterized by watery diarrhea, hypokalemia, and acidosis1 and in most cases is due to a non-β-islet-cell tumor of the pancreas that secretes vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine.2 When such tumors are localized to the pancreas, surgical resection may produce a cure, and in patients with metastatic disease streptozocin may reduce the tumor's size and control the symptoms.3 A variety of other agents — corticosteroids,4 lithium,5 metoclopramide,6 clonidine,7 trifluoperazine,8 and indomethacin9 — may also occasionally reduce the diarrhea, and continuous intravenous infusion of somatostatin has also been reported to reduce diarrhea and decrease plasma concentrations . . .
影响因子:
39.2
作者:
McArthur,KE;Anderson,DS;Durbin,TE;Orloff,MJ;Dharmsathaphorn,K
通讯作者:
Dharmsathaphorn,K
影响因子:
6.1
作者:
DePalatis,LR;Khorram,O;Ho,RH;Negro-Vilar,A;McCann,SM
通讯作者:
McCann,SM